静止性低血压与更高的循环内静止素水平有关
Fabrizio Ricci1,2,3, Anders Larsson4, Toralph Ruge1,5
1Department of Clinical Sciences, Lund University, Malmö, Sweden, Jan Waldenströms gata 35, 214 28 Malmö, Sweden.
European heart journal open
|May 6, 2024
概括
在患有正静性低血压 (OH) 的患者中,循环内静止素水平较高. 升高的内静止素可能表明OH患者心血管风险增加,需要进一步研究.
科学领域:
- 心血管生理学心血管生理学
- 内分泌学 在内分泌学.
背景情况:
- 静止性低血压 (OH) 是一种常见的疾病,病理生理学不明.
- 内静止素是一种血管生成抑制剂,与血压调节有关.
研究的目的:
- 调查循环内静素水平与正静性低血压之间的关联.
- 确定内静止素是否可以作为OH和相关心血管风险的生物标志物.
主要方法:
- 在146名OH患者和150名对照人群中,使用免疫试验比较内静止素水平.
- 采用线性和多变量逻辑回归分析.
- 根据年龄,性别,癌症,心血管疾病和风险因素进行调整.
主要成果:
- 在OH患者 (59,024 pg/mL) 和对照 (44,090 pg/mL) 中,内静止素水平显著更高.
- 在内静止素和静态血压下降之间观察到正线性相关性.
- 多变量分析证实了内静止素与OH的相关性 (aOR=1.264).
结论:
- 循环内静素的升高与正静性低血压有关.
- 内静止素可能是OH患者心血管风险的潜在临床标志物.
- 需要进一步的研究来验证发现并阐明机制.
相关概念视频
Alterations in Blood Pressure
1.2K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
Disorders of the Autonomic Nervous System
626
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
626
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
620
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
620
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
155
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
155


